Business Context and Reporting Period
This Form 8-K was filed by WellPoint, Inc. (now Elevance Health, Inc.) on June 8, 2007. The report details the closing of a debt offering on the same date, creating new direct financial obligations for the registrant.
Key Financial Metrics
The filing discloses the issuance of two series of senior notes with the following terms:
- 2017 Notes: $700,000,000 aggregate principal amount at 5.875% interest, maturing June 15, 2017.
- 2037 Notes: $800,000,000 aggregate principal amount at 6.375% interest, maturing June 15, 2037.
- Total Principal: $1,500,000,000.
- Net Proceeds: Approximately $1,478,282,000 after deducting underwriting discounts and offering expenses.
- Interest Payments: Payable semi-annually on June 15 and December 15, commencing December 15, 2007.
The filing text does not provide current revenue, profit, cash flow, or margin data, as this is a transaction-specific report rather than a periodic financial statement.
Material Changes and Use of Proceeds
The primary material change is the increase in long-term debt obligations. The Company intends to use the net proceeds for working capital and general corporate purposes, including the repurchase of shares of its common stock. The Indenture governing the notes does not prohibit or limit the incurrence of additional indebtedness.
Outlook, Risks, and Contingencies
Redemption Provisions: The Company may redeem the notes at its option. The redemption price is the greater of 100% of the principal amount or the present value of remaining payments discounted at the treasury rate plus a spread (15 basis points for 2017 Notes; 25 basis points for 2037 Notes).
Change of Control: If a change of control occurs and the notes are downgraded below investment grade by Moody's, S&P, and Fitch, the Company must offer to repurchase the notes at 101% of the principal amount plus accrued interest.
Events of Default: Default triggers include failure to pay principal or interest, breach of indenture terms (uncured for 60 days), or bankruptcy/insolvency proceedings.
Investor Verification Checklist
- Verify the exact net proceeds received ($1,478,282,000) against the gross principal ($1.5 billion) to confirm underwriting costs.
- Confirm the Company's current liquidity position to assess the ability to service the new semi-annual interest payments starting December 2007.
- Review the Company's share repurchase program status to determine if proceeds are being utilized as stated.
- Monitor credit rating agency actions (Moody's, S&P, Fitch) to assess exposure to the mandatory repurchase trigger upon a change of control.